Laboratory diagnosis of anthrax
The Food and Drug Administration has reviewed Idaho Technology's 510(k) application and cleared the Joint Biological Agent Identification and Diagnostic System (JBAIDS) for use as an aid in the laboratory of diagnosis of anthrax. The JBAIDS Anthrax Detection System can detect the gene components of Bacillus anthracis in a variety of environmental sample types, and also clinical blood samples as well as cultured organisms.
The JBAIDS was selected by the US Department of Defense as the platform for use in rapid identification of over ten deadly pathogens associated with bioterrorism and diseases of military interest. The FDA clearance allows testing of blood and laboratory culture samples to aid in the laboratory identification of B anthracis, with results in less than one hour. The current method of growing, isolating and identifying a culture can take as long as several days for results.
Light-powered DNA detection removes the need for PCR
Unlike PCR, which amplifies DNA sequences by making millions of copies of target DNA for...
Early Parkinson's detection with an RNA-based blood test
The test has the potential to alleviate the uncertainty faced by patients and clinicians,...
Biomarkers for SIDS found in blood samples
US researchers have revealed the fingerprints of sudden infant death syndrome (SIDS) within blood...
